World Investment Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
21,644
| – | – | ﹤0.01% | 1117 |
|
|
2025
Q1 | $5.84K | Sell |
21,644
-8,040
| -27% | -$2.17K | ﹤0.01% | 1044 |
|
|
2024
Q4 | $15.4K | Sell |
29,684
-3,000
| -9% | -$1.56K | ﹤0.01% | 995 |
|
|
2024
Q3 | $106K | Buy |
32,684
+2,000
| +7% | +$6.48K | ﹤0.01% | 883 |
|
|
2024
Q2 | $92.1K | Hold |
30,684
| – | – | 0.01% | 612 |
|
|
2024
Q1 | $143K | Buy |
+30,684
| New | +$143K | 0.02% | 386 |
|
|
2022
Q4 | – | Sell |
-12,700
| Closed | -$470K | – | 266 |
|
|
2022
Q3 | $470K | Hold |
12,700
| – | – | 0.11% | 137 |
|
|
2022
Q2 | $312K | Sell |
12,700
-1,500
| -11% | -$36.9K | 0.07% | 191 |
|
|
2022
Q1 | $383K | Hold |
14,200
| – | – | 0.08% | 172 |
|
|
2021
Q4 | $263K | Hold |
14,200
| – | – | 0.06% | 220 |
|
|
2021
Q3 | $372K | Buy |
14,200
+200
| +1% | +$5.24K | 0.08% | 167 |
|
|
2021
Q2 | $448K | Sell |
14,000
-500
| -3% | -$16K | 0.1% | 139 |
|
|
2021
Q1 | $486K | Sell |
14,500
-1,650
| -10% | -$55.3K | 0.12% | 119 |
|
|
2020
Q4 | $589K | Sell |
16,150
-350
| -2% | -$12.8K | 0.15% | 110 |
|
|
2020
Q3 | $621K | Sell |
16,500
-400
| -2% | -$15.1K | 0.21% | 74 |
|
|
2020
Q2 | $630K | Buy |
16,900
+2,900
| +21% | +$108K | 0.22% | 70 |
|
|
2020
Q1 | $478K | Buy |
14,000
+1,000
| +8% | +$34.1K | 0.22% | 70 |
|
|
2019
Q4 | $507K | Buy |
+13,000
| New | +$507K | 0.2% | 71 |
|